Carregant...

Cholesterol Efflux Capacity, Macrophage Reverse Cholesterol Transport, and Cardioprotective HDL

PURPOSE OF REVIEW: Randomized clinical trials provide strong evidence that pharmacological elevation of HDL-cholesterol (HDL-C) fails to reduce cardiovascular disease risk in statin-treated humans. It is thus critical to identify new metrics that capture HDL's cardioprotective effects. RECENT F...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Opin Lipidol
Autors principals: Hutchins, Patrick M., Heinecke, Jay W.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4617325/
https://ncbi.nlm.nih.gov/pubmed/26270810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOL.0000000000000209
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!